Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR3 | Q9UBY5 | 14/20 | 0.95 |
| ▸ | LPAR2 | Q9HBW0 | 10/20 | 0.95 |
| ▸ | LPAR1 | Q92633 | 7/20 | 0.95 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid Monododecyl Ester SCHEMBL118202 | 1.00 | LPAR3 (0.95) | LPAR3LPAR2LPAR1LPAR5CYP3A4 | |
| Hexadecyl Dihydrogen Phosphate SCHEMBL61625 | 1.00 | LPAR3 (0.95) | LPAR3LPAR2LPAR1LPAR5CYP3A4 | |
| SCHEMBL8340226 | 1.00 | LPAR3 (0.95) | LPAR3LPAR2LPAR1LPAR5CYP3A4 | |
| SCHEMBL4280475 | 1.00 | LPAR3 (0.95) | LPAR3LPAR2LPAR1LPAR5CYP3A4 | |
| SCHEMBL3409562 | 1.00 | LPAR3 (0.95) | LPAR3LPAR2LPAR1LPAR5CYP3A4 | |
| SCHEMBL28337300 | 1.00 | LPAR3 (0.95) | LPAR3LPAR2LPAR1LPAR5CYP3A4 | |
| Phosphoric Acid Monotetradecyl Ester SCHEMBL1007469 | 1.00 | LPAR3 (0.95) | LPAR3LPAR2LPAR1LPAR5CYP3A4 | |
| SCHEMBL3411900 | 1.00 | LPAR3 (0.95) | LPAR3LPAR2LPAR1LPAR5CYP3A4 | |
| SCHEMBL3256566 | 1.00 | LPAR3 (0.95) | LPAR3LPAR2LPAR1LPAR5CYP3A4 | |
| SCHEMBL11137451 | 1.00 | LPAR3 (0.95) | LPAR3LPAR2LPAR1LPAR5CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 132 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025049242-A2 | BIO-BASED BINDER COMPOSITION FOR COATING APPLICATIONS | ARKEMA INC. (US) | 2025-03-06 | — | — | WO | claimed |
| CN-114806601-B | Alkyl phosphinate composition and preparation method and application thereof | 江苏利思德新材料有限公司 | 2023-04-07 | — | — | CN | claimed |
| US-20170283691-A1 | QUANTUM DOT-CONTAINING COMPOSITIONS INCLUDING AN EMISSION STABILIZER, PRODUCTS INCLUDING SAME, AND METHOD | SAMSUNG ELECTRONICS CO LTD (KR) | 2017-10-05 | — | — | US | claimed |
| US-9701896-B2 | Quantum dot-containing compositions including an emission stabilizer, products including same, and method | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2017-07-11 | — | — | US | claimed |
| US-20150021521-A1 | QUANTUM DOT-CONTAINING COMPOSITIONS INCLUDING AN EMISSION STABILIZER, PRODUCTS INCLUDING SAME, AND METHOD | QD VISION, INC. (US) | 2015-01-22 | — | — | US | claimed |
| WO-2013078252-A1 | QUANTUM DOT-CONTAINING COMPOSITIONS INCLUDING AN EMISSION STABILIZER, PRODUCTS INCLUDING SAME, AND METHOD | QD VISION, INC. (US) | 2013-05-30 | — | — | WO | claimed |
| EP-2234675-A1 | ENHANCED PHOTOSTABILITY OF AVOBENZONE IN THE PRESENCE OF ZINC OXIDE USING PHOSPHATE-BASED EMULSIFIERS | Schering-Plough Healthcare Products, Inc. (US) | 2010-10-06 | — | — | EP | claimed |
| WO-2009079486-A1 | ENHANCED PHOTOSTABILITY OF AVOBENZONE IN THE PRESENCE OF ZINC OXIDE USING PHOSPHATE-BASED EMULSIFIERS | SCHERING-PLOUGH HEALTHCARE PRODUCTS, INC. (US) | 2009-06-25 | — | — | WO | claimed |
| US-20090155194-A1 | ENHANCED PHOTOSTABILITY OF AVOBENZONE IN THE PRESENCE OF ZINC OXIDE USING PHOSPHATE-BASED EMULSIFIERS | SCHERING-PLOUGH HEALTHCARE PRODUCTS, INC. | 2009-06-18 | — | — | US | claimed |
| EP-0674728-B1 | ANTISTATIC FINISH FOR DYEABLE SURFACTANT-CONTAINING POLY(M-PHENYLENE ISOPHTHALAMIDE) FIBERS | DU PONT (US) | 1996-07-10 | — | — | EP | claimed |
| EP-0674728-A1 | ANTISTATIC FINISH FOR DYEABLE SURFACTANT-CONTAINING POLY(M-PHENY LENE ISOPHTHALAMIDE) FIBERS. | DU PONT (US) | 1995-10-04 | — | — | EP | claimed |
| WO-1994015012-A1 | ANTISTATIC FINISH FOR DYEABLE SURFACTANT-CONTAINING POLY(M-PHENY LENE ISOPHTHALAMIDE) FIBERS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1994-07-07 | — | — | WO | claimed |
| US-5269952-A | Coating of potassium alkyl phosphate, and partially amidated polyalkyleneimine | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1993-12-14 | — | — | US | claimed |
| JP-9279479-A | — | — | None | — | — | JP | disclosed |
| JP-60141735-A | — | — | None | — | — | JP | disclosed |
| US-20260078264-A1 | Tintable Aqueous Paint Composition Having High Block and Scrub Resistance Containing Non-Fluorinated Additives | SWIMC LLC (US) | 2026-03-19 | — | — | US | disclosed |
| US-4256589-A | COMPRISING AN AMOUNT GREATER THAN 12 UP TO ABOUT 30 PERCENT BY WEIGHT OF THE PHOSPHATE; HIGH SPEED TEXTURIZING | EASTMAN KODAK COMPANY (US) | 1981-03-17 | — | — | US | disclosed |
| US-4169061-A | Fiber treating compositions | EASTMAN KODAK COMPANY (US) | 1979-09-25 | — | — | US | disclosed |
| US-4039715-A | ORGANIC ESTERS, WAXES, PARTIALLY ORIENTED YARN | EASTMAN KODAK COMPANY (US) | 1977-08-02 | — | — | US | disclosed |
| US-3951825-A | ORGANIC ESTERS | EASTMAN KODAK COMPANY (US) | 1976-04-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260078264-A1 | Tintable Aqueous Paint Composition Having High Block and Scrub Resistance Containing Non-Fluorinated Additives | PTPN11, PTPN9, PTPN1 | LPAR3 2414/4885LPAR2 3250/4885LPAR1 3115/4885 |
| US-20090155194-A1 | ENHANCED PHOTOSTABILITY OF AVOBENZONE IN THE PRESENCE OF ZINC OXIDE USING PHOSPHATE-BASED EMULSIFIERS | TYR, AP2S1, POLL | LPAR3 4113/4885LPAR2 4159/4885LPAR1 3937/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.